Literature DB >> 31082253

Cellular Vehicles Based on Neutrophils Enable Targeting of Atherosclerosis.

Yanan Xue1, Yue Wu1, Qianqian Wang1, Lingjing Xue1, Zhigui Su1, Can Zhang1.   

Abstract

Given the multiple interactions between neutrophils (NEs) and atherosclerosis (AS), in this study, we exploited NEs as cellular vehicles loaded with cationic liposomes for actively targeting atherosclerotic sites. The cellular vehicles based on NEs possess efficient internalization of cationic liposomes and sensitive response to the chemotaxis of atherosclerotic inflammatory cells, which ultimately realize the targeted delivery of the cargos into the target cells in vitro. Moreover, these effects also translated to significant enhancement of the accumulation of NEs' cargos into the atherosclerotic plaque in vivo after administering NE vehicles to the AS animal model. Consequently, cellular vehicles based on NEs could be a novel strategy for targeted delivery of payloads into atherosclerotic plaque, which would facilitate theranostics for AS and the development of anti-AS drugs to manage the disease.

Entities:  

Keywords:  atherosclerosis; cellular vehicles; inflammation; neutrophil; targeting delivery

Mesh:

Substances:

Year:  2019        PMID: 31082253     DOI: 10.1021/acs.molpharmaceut.9b00342

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.

Authors:  Yao Zhang; Na Diao; Christina K Lee; Hong Wei Chu; Lan Bai; Liwu Li
Journal:  Mol Ther       Date:  2019-09-23       Impact factor: 11.454

Review 2.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

Review 3.  Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis.

Authors:  Sindhu C Pillai; Ankita Borah; Eden Mariam Jacob; D Sakthi Kumar
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 4.  Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases.

Authors:  Yujie Su; Jin Gao; Puneet Kaur; Zhenjia Wang
Journal:  Pharmaceutics       Date:  2020-12-17       Impact factor: 6.321

5.  Associations between Circulating VEGFR2hi-Neutrophils and Carotid Plaque Burden in Patients Aged 40-64 without Established Atherosclerotic Cardiovascular Disease.

Authors:  Vadim Genkel; Ilya Dolgushin; Irina Baturina; Albina Savochkina; Karina Nikushkina; Anna Minasova; Alla Kuznetsova; Igor Shaposhnik
Journal:  J Immunol Res       Date:  2022-04-26       Impact factor: 4.493

Review 6.  Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases.

Authors:  Fangyu Yang; Jianjiang Xue; Guixue Wang; Qizhi Diao
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

7.  Associations between Hypertriglyceridemia and Circulating Neutrophil Subpopulation in Patients with Dyslipidemia.

Authors:  Vadim Genkel; Ilya Dolgushin; Irina Baturina; Albina Savochkina; Alla Kuznetsova; Lubov Pykhova; Igor Shaposhnik
Journal:  Int J Inflam       Date:  2021-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.